Medicaid Expansion Demos Give Drug Firms A Break From Rebates
Executive Summary
CMS has approved an expansion of Medicaid that would not include rebates for drugs used by the newly eligible population under the Affordable Care Act. The agency is also evaluating a demonstration from Iowa that does not collect drug rebates on individuals eligible under ACA.
You may also be interested in...
Big Data Transforming The Role Of Pharma, IBM Analytics Partner Says
Pharmaceutical companies are beginning to leverage big data to become more integrated into health care delivery, looking to care coordination and other “services adjacent to medicines,” IBM’s John Piccone reports.
CMS To Issue Guidance Interpreting Affordable Care Act's Effect On Medicaid Formularies
Confusion has arisen as to whether the health reform statute's changes to Medicaid drug rebates means that a state Medicaid program's fee-for-service and managed care organization formularies must be identical.
FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees
Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.